Objective: The objectives of this article are first to give an overview of the risks of bias in trial-based economic evaluations and, second, to identify how key sources for bias can be revealed and overcome (i.e. what bias-reducing strategies might be employed) in future trial-based economic evaluations in the field of health psychology. Design: Narrative review discussing sources of bias in trial-based economic evaluations and bias-reducing strategies. Results: We identified 11 biases and assigned them to a particular trial phase. A distinction is made between pre-trial biases, biases during the trial and biases that are relevant after the actual trial. All potential forms of bias are discussed in detail and strategies are shown to detect...
Introduction: This article is part of the series How to Prepare a Systematic Review (SR) of Economic...
Introduction: The statistical quality of many trial-based economic evaluations is poor. When conduct...
Rigorous treatment trial exhibit a number of key features to guard against bias. Randomization, blin...
Objective: The objectives of this article are first to give an overview of the risks of bias in tria...
Estimation of empirical relationships is prone to bias. Economists have carefully studied sources of...
Several biases can occur when performing economic evaluations (EE) and it is important for researche...
BACKGROUND: Evidence based medicine aims to integrate scientific evidence, clinical experience, and ...
The statistical quality of trial-based economic evaluations is often suboptimal, while a comprehensi...
Research on bias in clinical trials may help identify some of the reasons why investigators sometime...
Even though randomised controlled trials are the design of choice for evaluating the efficacy of hea...
In economic evaluations of new medical technologies, analysts often need to use data from randomized...
Abstract. Even though randomised controlled trials are the design of choice for evaluating the effic...
Objective: It has been suggested that randomised controlled trials (RCTs) of health behaviour change...
OBJECTIVE: It has been suggested that randomised controlled trials (RCTs) of health behaviour change...
Introduction: This article is part of the series How to Prepare a Systematic Review (SR) of Economic...
Introduction: The statistical quality of many trial-based economic evaluations is poor. When conduct...
Rigorous treatment trial exhibit a number of key features to guard against bias. Randomization, blin...
Objective: The objectives of this article are first to give an overview of the risks of bias in tria...
Estimation of empirical relationships is prone to bias. Economists have carefully studied sources of...
Several biases can occur when performing economic evaluations (EE) and it is important for researche...
BACKGROUND: Evidence based medicine aims to integrate scientific evidence, clinical experience, and ...
The statistical quality of trial-based economic evaluations is often suboptimal, while a comprehensi...
Research on bias in clinical trials may help identify some of the reasons why investigators sometime...
Even though randomised controlled trials are the design of choice for evaluating the efficacy of hea...
In economic evaluations of new medical technologies, analysts often need to use data from randomized...
Abstract. Even though randomised controlled trials are the design of choice for evaluating the effic...
Objective: It has been suggested that randomised controlled trials (RCTs) of health behaviour change...
OBJECTIVE: It has been suggested that randomised controlled trials (RCTs) of health behaviour change...
Introduction: This article is part of the series How to Prepare a Systematic Review (SR) of Economic...
Introduction: The statistical quality of many trial-based economic evaluations is poor. When conduct...
Rigorous treatment trial exhibit a number of key features to guard against bias. Randomization, blin...